nuvaring
organon pharma israel ltd., israel - ethinylestradiol; etonogestrel - vaginal ring - ethinylestradiol 2.7 mg; etonogestrel 11.7 mg - ethinylestradiol - ethinylestradiol - contraception. the safety and efficacy has been established in women aged 18 to 40 years.
evorel conti
truemed ltd. - estradiol as hemihydrate; norethisterone acetate - patches - estradiol as hemihydrate 3.2 mg; norethisterone acetate 11.2 mg - estradiol, combinations - estradiol, combinations - hormone replacement therapy for the relief of menopausal symptoms.
nuvaring
organon pharma israel ltd., israel - ethinylestradiol; etonogestrel - vaginal ring - ethinylestradiol 2.7 mg; etonogestrel 11.7 mg - ethinylestradiol - contraception. the safety and efficacy has been established in women aged 18 to 40 years.
gynera
bayer israel ltd - ethinylestradiol; gestodene - coated tablets - ethinylestradiol 0.03 mg; gestodene 0.075 mg - ethinylestradiol - hormonal contraception.
kaletra tablet 200mg50mg
abbvie pte. ltd. - lopinavir; ritonavir - tablet, film coated - 200.0mg - lopinavir 200.0mg; ritonavir 50.0mg
kaletra oral solution
abbvie pte. ltd. - lopinavir; ritonavir - syrup - 80 mg - lopinavir 80 mg; ritonavir 20 mg
kaletra
abbvie limited - lopinavir 100mg; ritonavir 25mg ((pharmacokinetic enhancer)) - film coated tablet - 100mg/25mg - active: lopinavir 100mg ritonavir 25mg ((pharmacokinetic enhancer)) excipient: colloidal silicon dioxide copovidone opadry yellow 85f32450 sodium stearyl fumarate sorbitan laurate - kaletra is indicated for the treatment of hiv-1 infection, in combination with other antiretroviral agents in adults and children aged 2 years and older.
kaletra
abbvie limited - lopinavir 200mg; ritonavir 50mg ((pharmacokinetic enhancer)) - film coated tablet - 200mg/50mg. - active: lopinavir 200mg ritonavir 50mg ((pharmacokinetic enhancer)) excipient: colloidal silicon dioxide hyprolose hypromellose copovidone, k value 28 iron oxide yellow macrogol 3350 macrogol 400 polysorbate 80 purified talc sodium stearyl fumarate sorbitan laurate titanium dioxide - kaletra is indicated for the treatment of hiv-1 infection, in combination with other antiretroviral agents in adults and children aged 2 years and older.
kaletra
abbvie limited - lopinavir 80 mg/ml; ritonavir 20 mg/ml ((pharmacokinetic enhancer)) - oral solution - active: lopinavir 80 mg/ml ritonavir 20 mg/ml ((pharmacokinetic enhancer)) excipient: acesulfame potassium ammonium glycyrrhizinate castor oil citric acid ethanol vanilla, natural and artifical 33869 cotton candy, artificial 30-92-0011 glycerol high fructose corn syrup levomenthol peppermint oil povidone propylene glycol purified water saccharin sodium sodium chloride sodium citrate dihydrate - kaletra is indicated for the treatment of hiv-1 infection, in combination with other antiretroviral agents in adults and children aged 2 years and older.
exviera 250mg tablets
abbvie ltd - dasabuvir sodium monohydrate - tablet - 250mg